EA201490270A1 - Ингибиторы aldh-2 для лечения зависимости - Google Patents

Ингибиторы aldh-2 для лечения зависимости

Info

Publication number
EA201490270A1
EA201490270A1 EA201490270A EA201490270A EA201490270A1 EA 201490270 A1 EA201490270 A1 EA 201490270A1 EA 201490270 A EA201490270 A EA 201490270A EA 201490270 A EA201490270 A EA 201490270A EA 201490270 A1 EA201490270 A1 EA 201490270A1
Authority
EA
Eurasian Patent Office
Prior art keywords
dependence
aldh
inhibitors
treatment
substances
Prior art date
Application number
EA201490270A
Other languages
English (en)
Inventor
Майкл Грауп
Чандрасекар Венкатарамани
Джефф Заблокки
Original Assignee
Джилид Сайэнс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Джилид Сайэнс, Инк. filed Critical Джилид Сайэнс, Инк.
Publication of EA201490270A1 publication Critical patent/EA201490270A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/36—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Abstract

Раскрыты новые производные изофлавона, имеющие структуру, соответствующую формуле Iкоторые являются ингибиторами ALDH-2, пригодными для лечения нуждающегося в этом пациента от зависимости от веществ, вызывающих зависимость, например от зависимости от вызывающих продукцию дофамина веществ, таких как кокаин, морфин, амфетамины, никотин и алкоголь.
EA201490270A 2011-08-30 2012-08-30 Ингибиторы aldh-2 для лечения зависимости EA201490270A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161529164P 2011-08-30 2011-08-30
PCT/US2012/053110 WO2013033377A1 (en) 2011-08-30 2012-08-30 Aldh-2 inhibitors in the treatment of addiction

Publications (1)

Publication Number Publication Date
EA201490270A1 true EA201490270A1 (ru) 2014-10-30

Family

ID=46982916

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201490270A EA201490270A1 (ru) 2011-08-30 2012-08-30 Ингибиторы aldh-2 для лечения зависимости

Country Status (15)

Country Link
US (1) US8673966B2 (ru)
EP (1) EP2751090A1 (ru)
JP (1) JP2014525457A (ru)
KR (1) KR20140057634A (ru)
CN (1) CN103764640A (ru)
AR (1) AR087700A1 (ru)
AU (1) AU2012300209B2 (ru)
BR (1) BR112014004943A2 (ru)
CA (1) CA2845796A1 (ru)
EA (1) EA201490270A1 (ru)
HK (1) HK1199729A1 (ru)
IL (1) IL230746A0 (ru)
MX (1) MX2014002270A (ru)
TW (1) TWI468403B (ru)
WO (1) WO2013033377A1 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016334396B2 (en) * 2015-10-09 2021-04-08 Northwestern University (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid, and related compounds as GABA aminotransferase inactivators for the treatment of epilepsy, addiction and hepatocellular carcinoma
WO2023244574A1 (en) 2022-06-14 2023-12-21 Amygdala Neurosciences, Inc. Aldh-2 inhibitor compounds and methods of use
US20230399299A1 (en) 2022-06-14 2023-12-14 Amygdala Neurosciences, Inc. Aldh-2 inhibitor compounds and methods of use

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US4326525A (en) 1980-10-14 1982-04-27 Alza Corporation Osmotic device that improves delivery properties of agent in situ
US5364620A (en) 1983-12-22 1994-11-15 Elan Corporation, Plc Controlled absorption diltiazem formulation for once daily administration
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US4992445A (en) 1987-06-12 1991-02-12 American Cyanamid Co. Transdermal delivery of pharmaceuticals
US5001139A (en) 1987-06-12 1991-03-19 American Cyanamid Company Enchancers for the transdermal flux of nivadipine
US4902514A (en) 1988-07-21 1990-02-20 Alza Corporation Dosage form for administering nilvadipine for treating cardiovascular symptoms
US5204369A (en) 1991-07-01 1993-04-20 The Endowment For Research In Human Biology Method for the inhibition of aldh-i useful in the treatment of alcohol dependence or alcohol abuse
EP1077697B1 (en) 1998-05-12 2006-07-19 The Endowment For Research In Human Biology, Inc. Methods and assays useful in the treatment of alcohol dependence or alcohol abuse
EP1645272A3 (en) * 1998-05-12 2008-11-05 The Endowment For Research In Human Biology, Inc. Daidzin derivatives for the treatment of alcohol dependence or alcohol abuse
KR20060011785A (ko) * 2002-06-27 2006-02-03 디 인다우먼트 포 리써치 인 휴먼 바이올로지, 인크. Ａｌｄｈ 억제에 유용한 화합물
JP2007297283A (ja) * 2004-07-28 2007-11-15 Santen Pharmaceut Co Ltd 新規桂皮酸関連化合物
MX2010008111A (es) * 2008-01-24 2010-11-30 Endowment For Res In Human Biology Inc Inhibidores de aldh-2 en el tratamiento de adicciones.

Also Published As

Publication number Publication date
KR20140057634A (ko) 2014-05-13
AU2012300209B2 (en) 2015-01-22
AU2012300209A1 (en) 2013-04-04
JP2014525457A (ja) 2014-09-29
HK1199729A1 (en) 2015-07-17
EP2751090A1 (en) 2014-07-09
US8673966B2 (en) 2014-03-18
TWI468403B (zh) 2015-01-11
US20130231325A1 (en) 2013-09-05
CN103764640A (zh) 2014-04-30
BR112014004943A2 (pt) 2017-03-21
CA2845796A1 (en) 2013-03-07
AR087700A1 (es) 2014-04-09
IL230746A0 (en) 2014-03-31
MX2014002270A (es) 2015-01-16
TW201331197A (zh) 2013-08-01
WO2013033377A1 (en) 2013-03-07

Similar Documents

Publication Publication Date Title
EA201491824A1 (ru) Производные бензамида для ингибирования активности abl1, abl2 и bcr-abl1
MX336381B (es) Boronatos como inhibidores de arginasa.
MX2014005928A (es) Inhibidores ciclicos de glutaminasa.
EA201301209A1 (ru) Производные пирролотриазинона в качестве ингибиторов p13k
EA201692506A2 (ru) Ингибиторы репликации вирусов гриппа
CR20140161A (es) Benzilindazoles sustituidos para uso como inhibidores de la quinasa bub1 en el tratamiento de enfermedades hiperproliferativas
EA201591527A1 (ru) Новые производные пиридина
EA201500362A1 (ru) Ингибиторы rho-киназы
EA201491028A8 (ru) Способ получения замещенных 5-фтор-1н-пиразолопиридинов
EA201492005A1 (ru) Бензамидные производные для ингибирования активности abl1, abl2 и bcr-abl1
EA201490269A1 (ru) Новое производное 1,2,3,4-тетрагидрохинолина, подходящее для лечения диабета
EA201391635A1 (ru) Соединения для лечения зависимости
MA33939B1 (fr) 5-alcynyl-pyrimidines
EA201500426A1 (ru) Производные пирролотриазинона в качестве ингибиторов pi3k
EA201390381A1 (ru) Триазиноксадиазолы
EA201591064A1 (ru) Новые производные пиридина
TN2012000578A1 (en) Tetrahydro-pyrido-pyrimidine derivatives
UY32432A (es) Compuestos de pirimidina fusionada como inhibidores de akt
EA201201677A1 (ru) Производные гетероарилимидазолона в качестве ингибиторов jak
EA201490474A1 (ru) Аминохиназолины в качестве ингибиторов киназ
EA201270280A1 (ru) Соединения пиримидина в качестве ингибиторов при лечении туберкулеза
EA201491227A1 (ru) Новые производные морфолинила, подходящие для применения в качестве ингибиторов mogat-2
MX2013005819A (es) Benzoxazepinas como inhibidores de 3-cinasa/objetivo mamífero de rapamicina (pi3k/mtor) metodos de uso y fabricacion.
EA201600097A1 (ru) Применение выбранных пиридон карбоксамидов или их солей в качестве активных веществ против абиотического стресса растений
EA201590656A1 (ru) Азаиндолины